Bionow’s Post

Fuelling productivity improvement in biotech! Faber Infinite celebrates another milestone, enhancing efficiency across the biotech sector. Our tailored solutions have streamlined workflows, fostering efficiency improvement & rapid growth. Join us on this journey of excellence, where every success story is a testament to our commitment towards driving productivity improvement. Let's shape the future of biotech together! #faberinfinite #innovative #businessgrowth #sucessstory

Can't stop admiring this marvel! Sound on for the full experience! Have questions about how the NEW Agilitech Biotech benchtop mixer can revolutionize your lab processes? Want to discuss customization options or get a personalized quote? Don't hesitate to drop us a message or reach out directly! Your biotech solutions are just a click away. Your solution, your timeline. #BiotechInnovation #CustomSolutions #GetInTouchNow

Shared lab spaces are a great way to reduce costs and accelerate progress for biotech start-ups. These spaces provide a streamlined launchpad complete with benches and a diverse network of industry mentors. If you're interested in learning more about co-working labs and how they can benefit your biotech start-up, check out the link below. #biotech #coworkinglabs

🚀 Supercharge Your Lab Workflow with Automation! 🚀 Discover the power of high-throughput screening with AIM Biotech's Organix and idenTx plate, which are now fully compatible with automated liquid handling systems! ⚙️ Embrace Automation: Say goodbye to the bottlenecks of manual processes. Our platforms integrate seamlessly with automatic liquid handlers, transforming the speed and scale of your experiments. 🔬 Increase Throughput: Whether it's drug discovery or cellular research, leverage the enhanced throughput to accelerate your screening and automated procedures. 📊 Precision & Reproducibility: With automation, not only do you get faster results, but you also achieve consistent precision and reproducibility, essential for groundbreaking scientific discoveries. ✅ Effortless Integration: Our user-friendly interfaces and protocols make it easy to adopt automation, so you can focus on what's important – your research. Don't let manual processes slow down your path to innovation. Explore how AIM Biotech can revolutionize your experimental workflows and catapult your research into the future. #AIMBiotech #LabAutomation #HighThroughput #DrugScreening #Organix #identiX #InnovationInResearch

In biotech, speed is everything. A skills-based strategy can help you decode the evolving skills market and prepare your team to innovate faster. Learn more in our latest blog post. Or join us for an in-person discussion on Oct. 22nd at 5pm at Mestizo. RSVP using the link in the comments below. #SkillsIntelligence #Innovation

Life Science experts Adrian Toutoungi and Nicholas Vollers, review the key considerations from the Bruntwood SciTech event, hosted at our Cambridge office, for TechBio investors, CEOs and founders considering their exit strategy: https://bit.ly/430qo1G   Key takeaways include the importance of defining your product, an analysis of the types of exit opportunities available to TechBio companies, considerations when valuing assets and platforms, and how to approach a pharma collaboration.   #LifeSciences #TechBioExits #TechBioInvestors #PrivateWealth

60 VC funding events in Biotechnology in the past 14 days!(see below) One of PitchBook's best covered VC verticals is Biotech. We even hired an in-house analyst to cover the space and release research reports. If you're fundraising or investing in this space, let's get in touch! We track cap tables(equity %, price per share, investors), patents, and clinical trial stages. #Biotech #Funding #PitchBook

📰 Exciting Moves at Nanophase Technologies 🌟 R. Janet Whitmore, a director at Nanophase Technologies, made headlines by purchasing $3.4k worth of company stock on 19 September 2024, at prices between $1.56 and $1.57 per share. Insider transactions like this often signal executive confidence in a company's future. Nanophase Technologies, specialising in advanced materials for cosmetics and industrial applications, reported a 32% revenue increase in Q2, indicating robust growth. Whitmore's investment might reflect this positive momentum 🚀. What are your thoughts? Does Whitmore's stock purchase influence your view on Nanophase? Let's chat in the comments. www.paiger.co #Investment #Nanophase #Finance

Small things that make a BIG impact 📈 We worked on the pitch deck for a Regenerative Medicine Company. It started with a simple question: How can we convey their innovative approach to investors? We knew that to stand out, we needed to focus on the details. So, we rolled up our sleeves and got to work 💪 Here's what we did: 1/ Color-coding 4 products 2/ Easy navigation 3/ Compelling imagery Want to see the transformation in action? 👀 Explore the full case study to see how attention to detail can elevate your pitch deck! #PitchDeck #Innovation #BioTech #InvestorPitch #DetailMatters

The biotech landscape is evolving rapidly, with emerging biopharma companies driving groundbreaking research and development. But how do they navigate the challenges of innovation—from securing IP to leveraging cutting-edge technology? On December 5th, join Patsnap at Frontier for a fireside chat with Jennifer Burdman, Managing Director at Sauvegarder Investment Management and a renowned expert in IP strategy and biotech innovation. With experience spanning high-stakes litigation, biotech IP portfolio development, and investment in cutting-edge innovations, Jennifer will share valuable insights into the future of life sciences. Whether you’re in R&D, legal, or investment, this session will inspire and inform. 💡 Save your spot now to gain actionable insights into the future of biopharma innovation: https://lnkd.in/grnbfFAX